ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Angiogenesis Inhibitors

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Growth Substances ∟ Angiogenesis Modulating Agents ∟ Angiogenesis Inhibitors 9 coordinate concepts ∟ Angiogenesis Inducing Agents \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Hormonal \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Myeloablative Agonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Growth Substances ∟ Growth Inhibitors ∟ Angiogenesis Inhibitors 9 coordinate concepts ∟ Angiogenesis Inducing Agents \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Hormonal \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Myeloablative Agonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Angiogenesis Inhibitors 9 coordinate concepts ∟ Angiogenesis Inducing Agents \| ∟ Antibiotics, Antineoplastic \| ∟ Anticarcinogenic Agents \| ∟ Antimetabolites, Antineoplastic \| ∟ Antimitotic Agents \| ∟ Antineoplastic Agents, Alkylating \| ∟ Antineoplastic Agents, Hormonal \| ∟ Antineoplastic Agents, Phytogenic \| ∟ Myeloablative Agonists X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Growth Substances ∟ Angiogenesis Modulating Agents ∟ Angiogenesis Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Growth Substances ∟ Growth Inhibitors ∟ Angiogenesis Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Antineoplastic Agents ∟ Angiogenesis Inhibitors Angiogenesis Modulating Agents > Growth Substances > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Growth Inhibitors > Growth Substances > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Antineoplastic Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
History note:	Neovascularization, Pathologic (1980-1999)X
historyNote*:	2004(2000); for ANGIOGENESIS FACTOR INHIBITORS use ANGIOGENESIS INHIBITORS (NM) 1981-2003 X
publicMeSHNote*:	2000; ANGIOGENSIS FACTOR INHIBITORS was indexed under PROTEINS 1981-2003 X
Scope note:	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. X
activeMeSHYear*:	2007X
dateCreated*:	1999-11-08X
dateEstablished*:	2000-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	jmpX
recordOriginator*:	jmpX
Type:	Concept X
Coordinate terms:	Angiogenesis Inducing Agents \| Antibiotics, Antineoplastic \| Anticarcinogenic Agents \| Antimetabolites, Antineoplastic \| Antimitotic Agents \| Antineoplastic Agents, Alkylating \| Antineoplastic Agents, Hormonal \| Antineoplastic Agents, Phytogenic \| Myeloablative Agonists X
URI:	X
Labels and equivalent concepts:	Angiogeneesin estäjät (fi) Angiogeneesin inhibiittorit (fi, replaced) Angiogeneesin inhibiittori (fi, replaced) Angiogeneesin estäjä (fi, replaced) Angiostaatit (fi, replaced) Angiostaatti (fi, replaced) Neovaskularisaation inhibiittorit (fi, replaced) Neovaskularisaation inhibiittori (fi, replaced) Neovaskularisaation estäjät (fi, replaced) Neovaskularisaation estäjä (fi, replaced) Angiogeneshämmare (sv) Neovascularization Inhibitors (en, replaced) Inhibitors, Neovascularization (en, replaced) Inhibitors, Angiogenic (en, replaced) Angiostatic Agents (en, replaced) Angiogenic Inhibitors (en, replaced) Angiogenic Antagonists (en, replaced) Angiogenetic Inhibitors (en, replaced) Antagonists, Angiogenic (en, replaced) Anti-Angiogenetic Agents (en, replaced) Inhibitors, Angiogenetic (en, replaced) Inhibitors, Angiogenesis (en, replaced) Antiangiogenic Agents (en, replaced) Anti-Angiogenic Drugs (en, replaced) Angiogenetic Antagonists (en, replaced) X
Share:	X